Study Completed

Erectile Dysfunction

Bayer Identifier:

11765

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

BAY38-7268, 20 mg Pharmburst FDT vs 20 mg Levitra

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

22 - 47 Years

Trial summary

Enrollment Goal

Trial Dates

September 2004 - October 2004

Phase

Phase 1

Could I Receive a placebo

N/A

Products

Levitra (Vardenafil, BAY38-9456)

Accepts Healthy Volunteer

N/A

Where to participate

Status	Institution	Location
Completed	MEDA Manufacturing GmbH, ClinPharmCologne	Köln, 51063, Germany

Trial design

Randomized, two-fold crossover study to investigate the relative bioavailability of 20 mg vardenafil oral disintegrating tablet in comparison to a 20 mg vardenafil standard tablet after single oral dosing in healthy male subjects

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.